LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon, Naiyer A. Rizvi, Rina Hui et al. · New England Journal of Medicine · 2015 · 6.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.4K citations · Full text

Medicine, Oncology, Pharmacology +12

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

New England Journal of Medicine · 2022 · 1.8K citations · Full text

Life Sciences, Immunology, Oncology +17

Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

Seng‐Ryong Woo, Meghan E. Turnis, Monica V. Goldberg et al. · Cancer Research · 2011 · 1.6K citations · Full text

Life Sciences, Immunology, Oncology +17

Broadly targeted human cytomegalovirus-specific CD4 <b>+</b> and CD8 <b>+</b> T cells dominate the memory compartments of exposed subjects

Andrew Sylwester, Bridget L. Mitchell, John B. Edgar et al. · The Journal of Experimental Medicine · 2005 · 1.3K citations · Full text

Life Sciences, Immunology, Infectious Diseases +17